Hosp Univ Vall D Hebron — Barcelona

Public research footprint of Hosp Univ Vall D Hebron, compiled from the ClinicalTrials.gov public registry.

106

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Lymphoma, Non-Hodgkin · Carcinoma, Non-Small-Cell Lung · Leukemia, Myeloid, Acute · Depressive Disorder, Major

Recently updated registry entries

NCT04175600 — A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary… (Active Not Recruiting)
NCT05850689 — Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major… (Recruiting)
NCT05049798 — A Study of Guselkumab and Interleukin-17 (IL-17) Inhibitor Therapies in Participants With… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Hosp Univ Vall D Hebron?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.